“… A few names have so far emerged as possible replacements: Brett Giroir, HHS’s assistant secretary for health; Amy Abernethy, the new FDA principal deputy commissioner; and Norman Sharpless, director of the National Cancer Institute.”
Read the full newsletter here.
Source: POLITICO Morning eHealth – March 6, 2019. POLITICO.
